Absolute Quantitation qPCR: Standard Curves and Reporting Tips

Why Absolute Quantitation for Residual DNA?

In biopharmaceutical QC, reporting a precise concentration is non-negotiable. Unlike relative quantitation used in gene expression studies, absolute quantitation provides a definitive value (e.g., copies/µL). This is especially critical when monitoring host cell DNA (HCD) levels in cell and gene therapy products.

Contextual Application: For instance, in HEK293/293T characterization, researchers specifically target stable genomic integration sites like E1A or SV40LTA to quantify residual risk with high sensitivity.

Mastering the Standard Curve

A reliable standard curve translates your raw Ct values into biological insights. To ensure the highest data quality, your curve should feature:

• Linearity (R² > 0.99): Indicates consistency across the entire dilution range.
• Efficiency (90-110%): A slope between -3.1 and -3.6 ensures the target is doubling accurately in each cycle.
• Low-Copy Precision: Using low-retention tips is vital when working with standards near the LOD to prevent sample loss.

Addressing Inhibition and Accuracy

Even a perfect standard curve can yield inaccurate results if the sample matrix inhibits the reaction. This is where Internal Positive Controls (IPC) become indispensable. By monitoring IPC behavior in every well, you can distinguish between a truly "negative" result and one suppressed by contaminants.

Understanding the role of IPC in preventing false negatives is a prerequisite for validating any residual DNA assay, as it provides an audit trail for individual sample performance.

Reporting Best Practices

When finalizing your assay report, clarity ensures regulatory compliance: